These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 7356509)

  • 21. Evaluation of the effects of cotinine and nicotine-N'-oxides on the development of tumors in rats initiated with N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide.
    LaVoie EJ; Shigematsu A; Rivenson A; Mu B; Hoffmann D
    J Natl Cancer Inst; 1985 Dec; 75(6):1075-81. PubMed ID: 3865011
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The pathogenesis of bladder cancer.
    Friedell GH; Jacobs JB; Nagy GK; Cohen SM
    Am J Pathol; 1977 Nov; 89(2):431-42. PubMed ID: 920778
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Urinary bladder carcinogenicity of N-[4-(5-nitro-2-furyl)-2-thiazolyl] formamide in female Swiss mice.
    Ertürk E; Cohen SM; Bryan GT
    Cancer Res; 1970 May; 30(5):1309-11. PubMed ID: 5426933
    [No Abstract]   [Full Text] [Related]  

  • 24. Early lesions in experimental bladder cancer: scanning electron microscopy of cell surface markers.
    Jacobs JB; Arai M; Cohen SM; Friedell GH
    Cancer Res; 1976 Jul; 36(7 PT 2):2512-7. PubMed ID: 1277159
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Light and scanning electron microscopy of exfoliated bladder epithelial cells in rats fed N-(4-(5-nitro-2-furyl)-2-thiazolyl)formamide.
    Jacobs JB; Arai M; Cohen SM; Friedell GH
    J Natl Cancer Inst; 1976 Jul; 57(1):63-6. PubMed ID: 1003508
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intravesical thio-tepa: a study of 3H-thymidine uptake in normal urothelium and FANFT-induced tumors in rats.
    Nieh PT; Daly JJ; Irwin RJ; Prout GR
    Invest Urol; 1979 May; 16(6):486-8. PubMed ID: 109416
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of the bladder carcinogen N-(4-(5-nitro-2-furyl)-2-thiazolyl)formamide on nucleic acids and total protein content of bladder epithelium undergoing malignant change.
    Pai SH; Amaral L; Werthamer S; Zak FG
    Invest Urol; 1974 Mar; 11(5):392-5. PubMed ID: 4815625
    [No Abstract]   [Full Text] [Related]  

  • 28. Ultrastructure and reversibility of bladder carcinoma of rats produced by feeding of N-(4-(5-nitro-2-furyl)-2-thiazolyl)formamide.
    Pai SH; Amaral L; Werthamer S; Zak FG
    Invest Urol; 1973 Sep; 11(2):125-35. PubMed ID: 4728260
    [No Abstract]   [Full Text] [Related]  

  • 29. Experimental bladder tumor induction, propagation, and therapy.
    Williams PD; Murphy GP
    Urology; 1976 Jul; 8(1):39-42. PubMed ID: 941358
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of peroxidase inhibitors on an in vivo metabolite of the urinary bladder carcinogen N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide in rats.
    Rice JR; Spry LA; Zenser TV; Davis BB
    Cancer Res; 1988 Jan; 48(2):304-9. PubMed ID: 3121171
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of feeding N-(4-(5-nitro-2-furyl)-2-thiazolyl)formamide on mitotic activity of rat urinary-bladder epithelium.
    Tiltman AJ; Friedell GH
    J Natl Cancer Inst; 1972 Jan; 48(1):125-9. PubMed ID: 4652369
    [No Abstract]   [Full Text] [Related]  

  • 32. Early lesions in experimental bladder cancer: experimental design and light microscopic findings.
    Cohen SM; Jacobs JB; Arai M; Johansson S; Friedell GH
    Cancer Res; 1976 Jul; 36(7 PT 2):2508-11. PubMed ID: 1277158
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of gonadectomy and hormone administration on the urinary bladder carcinogenicity of N-(4-(5-nitro-2-furyl)-2-thiazolyl)formamide in male and female Swiss mice.
    Yoshida O; Ertürk E; Bryan GT; Lower GM
    Invest Urol; 1973 Nov; 11(3):216-20. PubMed ID: 4749422
    [No Abstract]   [Full Text] [Related]  

  • 34. Production of urinary tract tumors by co-administration of uracil and N-[4-(5-nitro-2-furyl)-2-thiazolyl]-formamide in F344 rats.
    Wang CY; Kamiryo Y; Hayashida S; Croft WA
    Cancer Lett; 1987 Mar; 34(3):249-55. PubMed ID: 3828979
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative urinary and gallbladder carcinogenicity of N-(4-(5-nitro-2-furyl)-2-thiazolyl)formamide and N-(4-(5-nitro-2-furyl)-2-thiazolyl)acetamide in the dog.
    Ertürk E; Atassi SA; Yoshida O; Cohen SM; Price JM; Bryan GT
    J Natl Cancer Inst; 1970 Sep; 45(3):535-42. PubMed ID: 4331642
    [No Abstract]   [Full Text] [Related]  

  • 36. Retinyl acetate prophylaxis in cancer of the urinary bladder.
    Dawson WD; Miller WW; Liles WB
    Invest Urol; 1979 Mar; 16(5):376-7. PubMed ID: 429134
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of the application mode of N-[4-(5-nitro-2-furyl)-2-thiazolyl]-formamide on the localization of its carcinogenic expression in female NMRI-mice.
    Berger MR; Petru E; Habs M; Schmähl D
    Cancer Lett; 1986 Jun; 31(3):311-8. PubMed ID: 3719571
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro transformation of rat bladder epithelium by 2-amino-4-(5-nitro-2-furyl)thiazole.
    Mann AM; Masui T; Chlapowski FJ; Okamura T; Borgeson CD; Cohen SM
    Carcinogenesis; 1991 Mar; 12(3):417-22. PubMed ID: 2009588
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ultrastructure of cell junctions in FANFT-induced urothelial tumors in urinary bladder of Fischer rats.
    Pauli BU; Weinstein RS; Alroy J; Arai M
    Lab Invest; 1977 Dec; 37(6):609-21. PubMed ID: 599905
    [No Abstract]   [Full Text] [Related]  

  • 40. Ras involvement in cells transformed with 2-amino-4-(5-nitro-2-furyl)thiazole (ANFT) in vitro and with N-[4-(5-nitro-2-furyl)-2-thiazoyl]formamide in vivo.
    Mann AM; Asamoto M; Chlapowski FJ; Masui T; Macatee TL; Cohen SM
    Carcinogenesis; 1992 Sep; 13(9):1651-5. PubMed ID: 1394851
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.